CIK 0001515673 · Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272546083
- Phone
- 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Horn Howard Chief Financial Officer | Sale | −7,066 | $15.27 | $108K | 89,229 |
| 2026-09-15 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Sale 10b5-1 | −1,283 | $13.57 | $17K | 67,863 |
| 2026-09-03 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Sale | −161 | $13.99 | $2K | 69,146 |
| 2026-08-03 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale 10b5-1 | −1,900 | $24.92 | $47K | 92,562 |
| 2026-08-03 | Horn Howard Chief Financial Officer | Sale 10b5-1 | −4,696 | $24.92 | $117K | 96,295 |
| 2026-07-01 | Horn Howard Chief Financial Officer | Sale 10b5-1 | −4,698 | $33.13 | $156K | 100,991 |
| 2026-06-15 | Sanders Corazon (Corsee) D. Director | Sale | −2,000 | $25.05 | $50K | 21,095 |
| 2026-06-15 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale 10b5-1 | −1,899 | $24.62 | $47K | 94,462 |
| 2026-06-01 | Horn Howard Chief Financial Officer | Sale 10b5-1 | −4,653 | $23.77 | $111K | 105,689 |
| 2026-05-18 | SULIMAN SHEHNAAZ Director | Sale 10b5-1 | −5,740 | $25.12 | $144K | 27,951 |
| 2026-05-14 | Ray Amrit Director | Grant or award | +7,751 | 31,116 | ||
| 2026-05-14 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +14,058 | 14,058 | ||
| 2026-05-14 | Sanders Corazon (Corsee) D. Director | Grant or award | +7,751 | 23,095 | ||
| 2026-05-14 | Sanders Corazon (Corsee) D. Director | Grant or award · Stock Option (Right to Buy) | +14,058 | 14,058 | ||
| 2026-05-14 | SULIMAN SHEHNAAZ Director | Grant or award 10b5-1 | +7,751 | 33,691 | ||
| 2026-05-14 | SULIMAN SHEHNAAZ Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +14,058 | 14,058 | ||
| 2026-05-14 | Fust Matthew K Director | Grant or award | +7,751 | 33,696 | ||
| 2026-05-14 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +14,058 | 14,058 | ||
| 2026-05-14 | NARACHI MICHAEL Director | Grant or award | +7,751 | 40,441 | ||
| 2026-05-14 | NARACHI MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +14,058 | 14,058 |
Page 1 of 11 · 204 trades